ENDOLOGIX INC's ticker is and the CUSIP is 29266SAA4. A total of 15 filers reported holding ENDOLOGIX INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,023,000 | +189.8% | 1,062,000 | +180.2% | 0.01% | +150.0% |
| Q2 2016 | $353,000 | +5.7% | 379,000 | -15.0% | 0.00% | 0.0% |
| Q1 2016 | $334,000 | +13.2% | 446,000 | +30.8% | 0.00% | 0.0% |
| Q4 2015 | $295,000 | +14.8% | 341,000 | +18.0% | 0.00% | +100.0% |
| Q3 2015 | $257,000 | -75.1% | 289,000 | -73.0% | 0.00% | -80.0% |
| Q2 2015 | $1,031,000 | +854.6% | 1,070,000 | +890.7% | 0.01% | +400.0% |
| Q1 2015 | $108,000 | – | 108,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 51,117,000 | $46,140,000 | 1.90% |
| PFM Health Sciences, LP | 6,445,000 | $5,809,000 | 0.16% |
| Partner Investment Management, L.P. | 84,000 | $76,000 | 0.10% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,562,000 | $5,013,000 | 0.09% |
| OAKTREE CAPITAL MANAGEMENT LP | 6,000,000 | $5,423,000 | 0.08% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,095,000 | $1,004,000 | 0.04% |
| ACUTA CAPITAL PARTNERS, LLC | 96,000 | $86,000 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,500,000 | $1,352,000,000 | 0.03% |
| AMUNDI ASSET MANAGEMENT US, INC. | 7,305,000 | $6,557,000 | 0.02% |
| Citadel Advisors | 6,230,000 | $5,624,000 | 0.01% |